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Cell therapies for cartilage repair date back to 1987 when the
ﬁrst autologous chondrocyte implantation (ACI) procedure
was performed. Since then, more than 30,000 patients have
been treated with these techniques, which should not be
considered “experimental” anymore. Over the years, several
technical improvements have been implemented, leading to
incremental advances in the surgical procedure, as reviewed
by Y. Nam et al. However, a predictable, standardized, and
durable regeneration of hyaline cartilage tissue, capable to
withstand the mechanical forces acting in the joint and
to prevent joint degeneration, remains an unmet medical
need [1].
In this special issue entitled “Stem Cells for Cartilage
Regeneration: A Roadmap to the Clinic,” the authors
addressed several relevant topics, ranging from advanced
in vitro and in vivo models to alternative cell sources,
including induced pluripotent stem cells (iPS), and from
smart materials to additional target tissues with high unmet
medical need, such as the trachea or the temporomandibular
joint (TMJ).
A key bottleneck to improved therapies is represented by
reliable in vitro and in vivo models, capable to predict the
clinical outcome. Strong advances have been made in this
ﬁeld, towards the development of high-throughput systems
that allows testing multiple conditions with reproducible,
quick, and aﬀordable methods, and S. Lopa et al. provided a
comprehensive review of microﬂuidics and bioprinting
applications. Another important topic is quality control in
cell therapies, in order to better standardize the clinical
outcome. K. Shiraishi et al. reported an interesting study
analysis of mRNA and miRNA correlated with in vivo
cartilage repair, which may open new avenues for patient
stratiﬁcation and selection, beyond the mere quality
control. Regarding in vivo models, a translational model
capable to duplicate the challenging clinical scenarios has
yet to be developed. M. LoMonaco et al. reviewed extensively
this topic, ranging from small to large animal models and
providing critical insights for study planning.
The use of articular chondrocytes as a cell source has
been considered a bottleneck to a more robust and repro-
ducible regeneration of the articular surface, because of
their typical age-dependency and interdonor variability in
the cartilage-forming capacity [2]. For this reason, recent
research focused on alternative cell sources and experimen-
tal models in order to overcome the intrinsic limitations of
autologous cell therapies based on articular chondrocytes.
J. N. Fisher et al. reviewed recent advances in preclinical
and clinical research on a number of tissue sources of pro-
genitor cells for cartilage repair, highlighting pros and cons
of each of them, with a focus on the potential for clinical
translation. K. D. Jorgenson et al. presented a suspension
bioreactor incorporating microcarrier technology for the
eﬃcient culture of synovial ﬂuid-derived MSCs, which can
potentially support further research with this cell source.
Infrapatellar fat pad-derived cells gained attention because
of their easy accessibility and chondrogenic potential.
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J. F. C. do Amaral et al. reviewed the potential of infrapatellar
fat pad cells, discussing their potential for cartilage repair and
the ontogeny relationship with other joint-derived cells and
concluding with some perspective for translational trials
using this cell source. Another cell type that showed
promising preclinical data, with also a clinical trial ongoing,
is synovial MSC [3]. Y. Ikeda et al. reported a successful
approach to improve further the chondrogenic activity of
synovial MSC, without the upregulation of hypertrophic
and osteogenic genes, by enhanced IGF-1 expression. Last,
human-induced pluripotent stem cells (hiPSCs) gained a lot
of attention in the last decade, representing a new hope for
several life-threatening and incurable diseases. Y. A. Rim
et al. reported a relevant analysis of the chondrogenic
potential among hiPSCs from diﬀerent tissues: the ﬁnding
that cord blood mononuclear cells represent a better source
may support further research in this direction.
Biomaterials are a mainstay of regenerative medicine,
especially for articular cartilage. However, it is still a matter
of controversy whether a scaﬀold is strictly needed or not.
In this special issue, both approaches are reported. Interest-
ingly, F. Hached et al. reported the positive impact of a
polysaccharide hydrogel on encapsulated MSCs, with respect
to cell viability and ability to secrete potentially therapeutic
factors. Regarding scaﬀold-free approaches, M. P. Stuart
et al. reported a valuable method to engineer spheroids by
using a micromolded nonadhesive hydrogel, without the
use of growth factors.
In this special issue, the authors addressed a series of
topics of relevance for the successful translation of preclinical
approaches. Cell sources, biomaterials, animal models, and
cell manufacturing are all critical factors for cartilage repair,
which require additional work to pave the way to the next
generation of regenerative therapies, possibly capable to
restore durably both joint surface and function in patients
in need.
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